Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review.

Paola VillaValentina Elisabetta BounousInbal Dona AmarFederica BernardiniMargherita GiorgiDaniela Attianese Annamaria FerreroMarika D'OriaGiovanni Scambia

Published in: Journal of clinical medicine (2024)

HRT can be discussed with patients, evaluating the risks and benefits of hormone-dependent gynecological cancer. Counseling should be performed by gynecologic oncologists experienced in the management of these patients.

Keyphrases

end stage renal disease
ejection fraction
replacement therapy
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
young adults
risk assessment
patient reported
human immunodeficiency virus
squamous cell